Home › Funds › DF DENT & CO INC › RGEN

DF DENT & CO INC position in RGEN

REPLIGEN CORP · Health Care

DF DENT & CO INC reported holding 356,854 shares of RGEN (REPLIGEN CORP) in its Q2 2026 13F filing — a position valued at US$48.7M, representing 0.96% of its reported portfolio and ranking #31 among its reported holdings. DF DENT & CO INC has disclosed RGEN holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)356.85K sh
Reported value held$48.69M
Portfolio Weight0.96%
First reportedQ3 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How DF DENT & CO INC's RGEN position evolved

DF DENT & CO INC first disclosed a stake in RGEN in Q3 2023 at 381,493 shares (US$60.7M). The position peaked in Q3 2024 at 590,321 shares, worth US$87.9M. Across 12 filings, DF DENT & CO INC increased the stake 5 time(s), trimmed it 6 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 356,854 shares valued at US$48.7M — a reduction of -8,261 shares quarter over quarter.. Notable position changes include a 27% increase in Q4 2023 (shares rose 2% over the following quarter), a 31% increase in Q3 2024 (shares fell 3% over the following quarter), a 26% trim in Q1 2026 (shares rose 16% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 381.49K $60.66M New
Q4 2023 486.35K $87.45M Add
Q1 2024 439.88K $80.90M Reduce
Q2 2024 450.71K $56.82M Add
Q3 2024 590.32K $87.85M Add
Q4 2024 563.28K $81.08M Reduce
Q1 2025 574.68K $73.12M Add
Q2 2025 586.47K $72.95M Add
Q3 2025 534.72K $71.48M Reduce
Q4 2025 495.55K $81.20M Reduce
Q1 2026 365.12K $43.02M Reduce
Q2 2026 356.85K $48.69M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About RGEN and 13F data

RGEN (REPLIGEN CORP) is a Health Care company. 33 other funds we track also report a position in RGEN — the largest reported positions include UNITED CAPITAL FINANCIAL ADVISORS, LLC (US$380.8M), Maverick Capital (US$270.8M), MAVERICK CAPITAL LTD (US$270.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RGEN

All RGEN fund holders →

FAQ

How long has DF DENT & CO INC held RGEN?

DF DENT & CO INC has disclosed RGEN holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is DF DENT & CO INC's current position in RGEN?

As of Q2 2026, DF DENT & CO INC holds 356.85K shares of RGEN (REPLIGEN CORP), valued at $48.69M, representing 0.96% of its reported portfolio and ranking #31.

Has DF DENT & CO INC been buying or selling RGEN?

In the latest 13F filing (Q2 2026), DF DENT & CO INC reduced its position in RGEN. The position peaked in Q3 2024 at 590.32K shares.

Which other funds hold RGEN?

Other major institutional holders of RGEN include UNITED CAPITAL FINANCIAL ADVISORS, LLC, Maverick Capital, MAVERICK CAPITAL LTD, among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.